Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | 958 220 | déclaré | 13 mars 2026 | tx 246+6 965 638−3 071 903 |
| TESARO, Inc. | 444 124 | déclaré | 29 mars 2016 | tx 2+7 000−7 000 |
| COGNITION THERAPEUTICS INC | 48 500 | déclaré | 18 juin 2025 | tx 7+79 670 |
| scPharmaceuticals Inc. | 0 | déclaré | 07 oct. 2025 | tx 14+123 022−77 174 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 13 mars 2026 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 120 | 51.75 USD | |
| 13 mars 2026 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 10 742 | 51.00 USD | |
| 13 mars 2026 | OTHER | SUPERNUS PHARMACEUTICALS, INC. | 12 500 | — | |
| 13 mars 2026 | OTHER | SUPERNUS PHARMACEUTICALS, INC. | 12 500 | — | |
| 13 mars 2026 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 24 138 | 50.09 USD | |
| 06 mars 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 38 640 | 0.00 USD | |
| 06 mars 2026 | TAX_WITHHOLDING | SUPERNUS PHARMACEUTICALS, INC. | 16 574 | 54.73 USD | |
| 06 mars 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 38 640 | 0.00 USD | deriv |
| 28 févr. 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 38 640 | 0.00 USD | deriv |
| 18 févr. 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 341 610 | 0.00 USD | deriv |
| 09 oct. 2025 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 81 250 | 25.30 USD | |
| 09 oct. 2025 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 58 371 | 50.55 USD | |
| 09 oct. 2025 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 1 529 | 51.46 USD | |
| 09 oct. 2025 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 81 250 | 0.00 USD | deriv |
| 07 oct. 2025 | TENDER | scPharmaceuticals Inc. | 5 000 | — | |
| 07 oct. 2025 | OTHER | scPharmaceuticals Inc. | 19 750 | 0.00 USD | deriv |
| 07 oct. 2025 | OTHER | scPharmaceuticals Inc. | 16 300 | 0.00 USD | deriv |
| 07 oct. 2025 | OTHER | scPharmaceuticals Inc. | 6 124 | 0.00 USD | deriv |
| 07 oct. 2025 | OTHER | scPharmaceuticals Inc. | 30 000 | 0.00 USD | deriv |
| 02 oct. 2025 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 2 267 | 25.30 USD | |
| 02 oct. 2025 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 1 904 | 48.06 USD | |
| 02 oct. 2025 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 2 267 | 0.00 USD | deriv |
| 02 oct. 2025 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 19 320 | 0.00 USD | |
| 02 oct. 2025 | TAX_WITHHOLDING | SUPERNUS PHARMACEUTICALS, INC. | 7 529 | 46.21 USD | |
| 02 oct. 2025 | TAX_WITHHOLDING | SUPERNUS PHARMACEUTICALS, INC. | 7 796 | 46.21 USD |
2 achats déclarés après au moins 12 mois de silence — dernière occurrence le 03 déc. 2021.